RENEGADE THERAPEUTICS CORP. Trademark

Trademark Overview


On Tuesday, November 22, 2022, a trademark application was filed for RENEGADE THERAPEUTICS CORP. with the United States Patent and Trademark Office. The USPTO has given the RENEGADE THERAPEUTICS CORP. trademark a serial number of 97688772. The federal status of this trademark filing is ABANDONED - EXPRESS as of Monday, January 30, 2023. This trademark is owned by RENEGADE Therapeutics Corp.. The RENEGADE THERAPEUTICS CORP. trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of autoimmune diseases, multiple sclerosis, Crohn's disease, ulcerative colitis, inflammatory disorders, neurological disorders, neurodegenerative disorders, and Epstein-Barr virus associated lymphoproliferative disorders
renegade therapeutics corp.

General Information


Serial Number97688772
Word MarkRENEGADE THERAPEUTICS CORP.
Filing DateTuesday, November 22, 2022
Status601 - ABANDONED - EXPRESS
Status DateMonday, January 30, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment of autoimmune diseases, multiple sclerosis, Crohn's disease, ulcerative colitis, inflammatory disorders, neurological disorders, neurodegenerative disorders, and Epstein-Barr virus associated lymphoproliferative disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 25, 2022
Primary Code005
First Use Anywhere DateMonday, November 1, 2021
First Use In Commerce DateWednesday, October 12, 2022

Trademark Owner History


Party NameRENEGADE Therapeutics Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressScarsdale, NY 10583

Trademark Events


Event DateEvent Description
Monday, January 30, 2023ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Monday, January 30, 2023ABANDONMENT - EXPRESS MAILED
Friday, January 27, 2023TEAS EXPRESS ABANDONMENT RECEIVED
Friday, November 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 25, 2022NEW APPLICATION ENTERED